Canaccord Genuity Maintains a 'Hold' on Intuitive Surgical (ISRG); Q1 Should Beat, But Valuation Fully Accounts For Strong Growth
Tweet Send to a FriendGet Alerts ISRG Hot Sheet
Price: $484.00 +1.63%
Rating Summary:
18 Buy, 3 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
18 Buy, 3 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade ISRG Now!
Canaccord Genuity maintains a 'Hold' on Intuitive Surgical (NASDAQ: ISRG).
Analyst, Jason R. Mills, said, "We expect ISRG to report Q1 results in line with our estimates and beat what we see as an acquiescent consensus. Based on performance over the past two years, investors have come to expect upside to stated guidance. While we think ISRG could see macro-driven weakness in Europe in 2012, the company has several new product “greenfields”– not to mention new geographic opportunities (i.e. Japan) ”– that provide a range of potential growth opportunities in 2012, in our view."
"We model Q1/11 sales of $476.2M (+23% Y/Y) with Systems of $198.0M (+19% Y/Y), Instruments of $201.5M (+28% Y/Y) and Service of $76.7M (+21% Y/Y). Consensus is at $463.8M...We model Q1 EPS of $3.54 (+37% Y/Y) and operating income of $188M (OM of 39.4%). Consensus EPS stands at $3.14."
For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.
Shares of Intuitive Surgical closed at $546.56 yesterday, with a 52 week range of $320.00-$554.13.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jason R. Mills, said, "We expect ISRG to report Q1 results in line with our estimates and beat what we see as an acquiescent consensus. Based on performance over the past two years, investors have come to expect upside to stated guidance. While we think ISRG could see macro-driven weakness in Europe in 2012, the company has several new product “greenfields”– not to mention new geographic opportunities (i.e. Japan) ”– that provide a range of potential growth opportunities in 2012, in our view."
"We model Q1/11 sales of $476.2M (+23% Y/Y) with Systems of $198.0M (+19% Y/Y), Instruments of $201.5M (+28% Y/Y) and Service of $76.7M (+21% Y/Y). Consensus is at $463.8M...We model Q1 EPS of $3.54 (+37% Y/Y) and operating income of $188M (OM of 39.4%). Consensus EPS stands at $3.14."
For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.
Shares of Intuitive Surgical closed at $546.56 yesterday, with a 52 week range of $320.00-$554.13.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- Pier 1 Imports (PIR) Sets Sights on Growing Ecommerce
- Supernus (SUPN) PT Trimmed at Jefferies, But Survey Shows Significant Market Opportunity
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
